PharmaSGP Holding SE — Director's Dealing 2022

May 30, 2022

News Details

Directors’ Dealings | 30 May 2022 12:47

DGAP-DD: PharmaSGP Holding SE english

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

30.05.2022 / 12:46

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Name and legal form:	FUTRUE GmbH

2. Reason for the notification

a) Position / status

Person closely associated with:
Title:	Dr.
First name:	Clemens
Last name(s):	Fischer
Position:	Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

PharmaSGP Holding SE

b) LEI

3912005CZ12PVVCIPT91

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE000A2P4LJ5

b) Nature of the transaction

Purchase order for up to 150,000 shares of PharmaSGP Holding SE at market-preserving conditions in the period from May 30, 2022 to November 1, 2022 at the latest at a maximum purchase price of EUR 28.00 per share; settlement order terminable with notice of 2 stock exchange trading days.

c) Price(s) and volume(s)

Price(s)	Volume(s)
not numberable	not numberable

d) Aggregated information

Price	Aggregated volume
not numberable	not numberable

e) Date of the transaction

2022-05-27; UTC+2

f) Place of the transaction

Outside a trading venue

---

30.05.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de

---

Language:	English
Company:	PharmaSGP Holding SE
	Lochhamer Schlag 21
	82166 Gräfelfing
	Germany
Internet:	https://pharmasgp.com

End of News	DGAP News Service